ABOUT US Overview Management Board Scientific Advisors Partnerships
TECHNOLOGY INxin™ Platform PORxin™ Platform Scientific Conferences Publications
PRODUCTS Pipeline PRX321
PRX302
Clinical Trials Links
INVESTORS News Downloads Stock Events Calendar FAQ
NEWS & MEDIA News Media Coverage Media Kit Events Calendar
CAREERS Mission About Vancouver Current Opportunities
CONTACT US
2006 Protox Therapeutics Inc. All Rights Reserved. Legal Disclaimer.
June 2 2010 Protox Announces Positive Six Month Phase 2B BPH Results
June 1, 2010 Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association
May 13, 2010 Protox Reports First Quarter 2010 Financial Results
April 29, 2010 Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease
January 11, 2010 - 8:45 am ET Protox Therapeutics Conference Call - Webcast Link
